🔎 Trials Near Me

Home › Mga Sakit sa Pagtunaw › Texas

Pag-aaral pangklinika para sa Mga Sakit sa Pagtunaw sa Texas

13 pag-aaral para sa Mga Sakit sa Pagtunaw ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research, Baytown
  • DHR Health Gastroenterology - Edinburg, Edinburg
  • Baylor College of Medicine, Houston
  • at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06598943

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Texas Oncology - West Texas, Abilene
  • Texas Oncology - West Texas, Amarillo
  • Texas Oncology - Gulf Coast, Beaumont
  • at 27 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

  • Texas Liver Institute, San Antonio
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07654283

Product Surveillance Registry

  • Austin
  • Dallas
  • Fort Worth
  • at 6 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2026 · NCT01524276

Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children

  • Baylor College of Medicine/Texas Children's Hospital, Austin
  • Baylor College of Medicine / Texas Children's Hospital, Houston
Nagre-recruit
Edad 7 hanggang 12 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07222943

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Amarillo
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • at 21 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Amarillo
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • at 30 pa
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06318169

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

  • University of Texas Health Science Center at Houston, Houston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07351071

Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.

  • Methodist Dallas Medical Center- Clinical Research Institute, Dallas
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT07494318

Evaluation of Hepato-Pancreato-Biliary

  • Methodist Dallas Medical Center- Clinical Research Institute, Dallas
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT07565454

Gastroparesis Registry 4

  • Texas Tech University Health Science Center (TTUHSC), El Paso
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT05846802

GpCRC Pediatric Gastroparesis Registry 2

  • Texas Tech University Health Science Center, El Paso
  • Baylor College of Medicine/Texas Children's Hospital, Houston
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 25 · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT05981300

Endoscopic Retrograde Cholangiopancreatography

  • Methodist Dallas Medical Center- Clinical Research Institute, Dallas
Nagre-recruitObservasyonal na pag-aaral
Edad 15 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT07490132

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.